© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

South Korea

  • South Korea’s green and sustainable bond market is thriving this year. The country is already streets ahead of its peer China, with its sovereign printing a green deal and issuers embracing new twists on these financings. That forward-thinking mentality is just the beginning.
  • The blossoming green bond market in Asia is showing no signs of stopping, with a recent boom in issuance also seen in sustainability-linked bonds. As issuance for environmentally and socially conscious debt gathers momentum globally, Asia is fuelling the fire. Morgan Davis reports.
  • South Korea’s Kookmin Bank has sold its maiden dollar-denominated Basel III compliant additional tier one bond, opting for a sustainability label to entice investors.
  • The Export-Import Bank of Korea (Kexim) sealed a $1bn transaction on Tuesday with a combination of floating and fixed rate notes, on the back of a nearly seven times subscribed deal at its peak.
  • Korea Electric Power Corp (Kepco) made a remarkable return to the debt market on Monday, selling a $500m green bond as its first public dollar deal in 15 years.
  • The Republic of Korea issued a dual-tranche dollar bond on Wednesday, with the shorter dated portion carrying a green and sustainability label.
  • South Korean oil refiner GS Caltex Corp raised $300m from a senior bond on Wednesday.
  • KEB Hana Bank turned its attentions to Taiwan on Tuesday, raising $400m in a Formosa bond sale.
  • Biopharmaceuticals company Mabpharm launched bookbuilding for its up to HK$1.53bn ($195m) flotation, while Hansoh Pharmaceutical Group set pre-marketing in motion for its Hong Kong listing.
  • SG moves London banker to run Asia syndicate team — Citi loses head of India DCM — ANZ loans banker to relocate to Singapore — MSCI names Korea client head.
  • JP Morgan’s private equity arm has bagged W390.7bn ($327.5m) after selling a chunk of shares in South Korean firm Celltrion Healthcare, according to a source close to the deal.
  • South Korean company SK Biopharmaceuticals is planning to launch an IPO by the end of 2019 and could net proceeds of up to around W1tr ($838.5m), according to a source close to the deal.